Xeris Biopharma Holdings, Inc.

XERS

A reverse discounted cash flow for Xeris Biopharma Holdings, Inc. starts from what it has actually filed: the 2025 revenue and margin on this company's own statements. It asks what growth the current price is already assuming. That needs a live price, which is the one figure on this site that costs money to fetch, so it runs on an account rather than on a page anybody can open.

Valuation

Seeded from XERS’s own filed revenue, margin and trading multiples, against a live price. An account is what lets this run, for the reason above.

Low · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

Base · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

High · XXX×

XXX

Implied market cap: XXX
Total change: XXX
Annualised: XXX

Run the numbers on Xeris Biopharma Holdings, Inc. yourself.

Ten seconds, no card, and nothing to cancel.

Free 3-day Measure trial·No card, no broker connection.

Email address

Continue with Google

What an account lets you do with Xeris Biopharma Holdings, Inc.

Ask what growth the price is already betting on
A reverse DCF on XERS's filed revenue and margin, run against the price right now, not a guess about the future.
See every filed year, not just the recent ones
The statements this company has actually filed, in the way it filed them.
Every year on recordMeasure
Ask about any of it, get the filing back
The assistant answers from this company's own statements, and links every figure straight to its source.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.